SynthesisClinical rheumatology2021

Efficacy and safety of rituximab therapy in patients with systemic sclerosis disease (SSc): systematic review and meta-analysis.

Maliheh Moradzadeh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.